Long-Term Mental Health and Wellbeing Outcomes Associated with Naturalistic Ayahuasca Consumption
This naturalistic longitudinal study (n=66) investigates the long-term effects of ayahuasca on mental health in adults with no prior exposure. Participants attending neo-shamanic ceremonies reported sustained improvements in depression, anxiety, stress, affect, personality traits, spirituality, and relationships up to 12 months. Individuals with depression or anxiety experienced lasting symptom reductions, while those without a diagnosis had short-term benefits. Alcohol and cannabis use decreased only at one month. Findings suggest ayahuasca's mental health benefits persist, with varying trajectories of change over time.
Authors
- Michael Bogenschutz
- Daniel Perkins
- Joseph Sarris
Published
Abstract
The durability of ayahuasca’s effects on mental health and the influence of clinical diagnoses on therapeutic response is unclear. Adults with no prior exposure to ayahuasca (n = 66) participating in neo-shamanic ayahuasca ceremonies completed questionnaires at baseline, 7 days, and 1, 6, and 12 months. Mixed models were used to characterize temporal trajectories in mental health, alcohol and cannabis use, affect, personality, spirituality, and relationships and examine the longevity of effects in individuals with and without a depressive or anxiety disorder. After multiple comparison correction, ayahuasca use was associated with decreases in depression, anxiety, stress, negative affect, negative emotionality, acceptance of external influence, and self-alienation at all time points. Improvements in mental health, self-efficacy, and spirituality were observed up to 12 months post-ceremony. Individuals with depression and anxiety diagnoses maintained significant symptom reductions, whereas those without a diagnosis experienced short-term benefits. Decreases in alcohol and cannabis use were only observed at month 1. Naturalistic ayahuasca use was associated with persisting improvements in mental health and wellbeing, with the largest magnitude of symptom reduction observed in those diagnosed with a depressive or anxiety disorder. Differing trajectories of change were identified across psychological constructs, suggestive of both enhancement and attenuation of gains over time.
Research Summary of 'Long-Term Mental Health and Wellbeing Outcomes Associated with Naturalistic Ayahuasca Consumption'
Introduction
Ayahuasca is a plant-based psychedelic brew containing N,N-dimethyltryptamine (DMT) and harmala alkaloids that enable oral activity. Earlier clinical trials, prospective observational studies, and large cross-sectional surveys have reported rapid and sometimes durable reductions in depression and anxiety symptoms following ayahuasca use, as well as improvements in life satisfaction, mindfulness, cognitive flexibility, empathy, and connectedness. Nevertheless, uncertainty remains about how long psychological changes persist after a single exposure, whether negative long-term consequences occur, and whether therapeutic benefits differ between people with and without formal psychiatric diagnoses. Pagni Bap and colleagues set out to characterise trajectories of mental health, substance use, wellbeing, personality, spirituality, body connection, and interpersonal relationships over 12 months in ayahuasca‑naive adults who participated in neo‑shamanic ceremonies. A further aim was to examine whether lifetime diagnoses of depressive or anxiety disorders influence the longevity of antidepressant or anxiolytic effects. The study therefore provides longitudinal naturalistic data on first‑time ayahuasca users to inform questions about durability and diagnostic moderators of effect.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Pro members can view the original manuscript directly in the browser.
Study Details
- Study Typeindividual
- Journal
- Compound
- Topics
- Authors
- APA Citation
Pagni, B., Halman, A., Sarris, J., Chenhall, R., Bogenschutz, M., & Perkins, D. (2025). Long-Term Mental Health and Wellbeing Outcomes Associated with Naturalistic Ayahuasca Consumption. Journal of Psychoactive Drugs, 1-11. https://doi.org/10.1080/02791072.2025.2465800
References (20)
Papers cited by this study that are also in Blossom
Bathje, G. J., Fenton, J., Pillersdorf, D. et al. · Journal of Humanistic Psychology (2021)
Bouso, J. C., González, D., Fondevila, S. et al. · PLOS ONE (2012)
Maia, L. O., Massarentti, C. M., Tófoli, L.F. · Psychopharmacology (2022)
Jiménez-Garrido, D. F., Gómez-Sousa, M., Ona, G. et al. · Scientific Reports (2020)
Kiraga, M. K., Mason, N. L., Uthaug, M. V. et al. · Frontiers in Pharmacology (2021)
Kohek, M., Ona, G., Dos Santos, R. G. et al. · Journal of Psychoactive Drugs (2022)
Lawn, W., Hallak, J. E., Crippa, J. A. et al. · Scientific Reports (2017)
Murphy-Beiner, A., Soar, K. · Psychopharmacology (2020)
Netzband, N., Ruffell, S., Linton, &. S. et al. · Psychopharmacology (2020)
Palhano-Fontes, F., Barreto, D., Onias, H. et al. · Psychological Medicine (2018)
Show all 20 referencesShow fewer
Perkins, D., Opaleye, E. S., Simonová, H. et al. · Drug and Alcohol Review (2021)
Perkins, D., Pagni, B. A., Sarris, J. et al. · Frontiers in Pharmacology (2022)
Perkins, D., Ruffell, S. G. D., day, K. et al. · Frontiers in Neuroscience (2023)
Perkins, D., Schubert, V., Simonová, H. et al. · Frontiers in Pharmacology (2021)
Ruffell, S. G. D., Netzband, N., Tsang, W. et al. · Frontiers in Psychiatry (2021)
Rush, B., Marcus, O., García, S. et al. · Journal of Studies on Alcohol and Drugs (2024)
Dos Santos, R. G., Osório, F. L., Hallak, J. E. · Archives of Clinical Psychiatry (São Paulo) (2018)
Uthaug, M. V., Mason, N. L., Toennes, S. W. et al. · Psychopharmacology (2021)
Ramaekers, J. G. · Psychopharmacology (2022)
Weiss, B., Miller, J. D., Carter, N. T. et al. · Scientific Reports (2021)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.